*Some Market data delayed by 15 mins.

Cingulate Inc. Common Stock

Symbol: CING (NASDAQ)
0.45 ▼ (-6.74%) -0.032

Company Description:
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Key Stats
  • Today's Open: $0.45
  • Today's High: $0.601
  • Today's Low: $0.413
  • Today's Volume: 1.46M
  • Yesterday Close: $0.4804
  • Yesterday High: $0.5585
  • Yesterday Low: $0.4606
  • Yesterday Volume: 1.38M
  • Last Min Volume: 781
  • Last Min High: $0.448
  • Last Min Low: $0.439
  • Last Min VWAP: $0.4391
Company Profile
  • Name: Cingulate Inc. Common Stock
  • Website: https://www.cingulate.com
  • Listed Date: 2021-12-08
  • Location: KANSAS CITY, KS
  • Market Status: Active
  • CIK Number: 0001862150
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $4.03M
  • Round Lot: 100
  • Outstanding Shares: 9.37M
  • Asset Type: CS
RECENT FILINGS FOR CING
Filing DateFiling TypeFormat
2024-07-12PRE 14AView
2024-07-12DEFA14AView
2024-07-02SC 13D/AView
2024-07-024View
2024-07-024View
2024-07-018-KView
2024-06-28DEF 14AView
2024-06-27SC 13D/AView
2024-06-18PRE 14AView
2024-06-188-KView
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-128-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.